Related Articles
Bcl‑2/Bcl‑xL inhibitor ABT‑737 sensitizes pancreatic ductal adenocarcinoma to paclitaxel‑induced cell death
Combined treatment with ABT-737 and VX-680 induces apoptosis in Bcl-2- and c-FLIP-overexpressing breast carcinoma cells
Expression of connexin 32 and connexin 43 in acute myeloid leukemia and their roles in proliferation
Therapeutic potential of Bcl-xl/Mcl-1 synthetic inhibitor JY-1-106 and retinoids for human triple-negative breast cancer treatment
ABT‑737 increases cisplatin sensitivity through the ROS‑ASK1‑JNK MAPK signaling axis in human ovarian cancer cisplatin‑resistant A2780/DDP cells